YAP1 and breast cancer: This was confirmed by research by Dr. Maziarz, who showed that the Arg-200 mutation of GNA13 in BC can significantly increase YAP/TAZ transcriptional activity by upregulating the RhoGEF-Rho GTPase cascade in TCGA database and cellular experiments (51)(Figure 3A).